Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib…

Overview of attention for article published in Clinical Drug Investigation, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 1 X post from an account with 379 followers.

Gestion des EI: T-DM1 Ca$3500 vs. cape+lapa Ca$7000 par patient dans les cancers du sein avancé ou métastatique. http://t.co/GvMWXPH5CV

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.